Search clinical trials for: CCX168
Total 33 results
-
ChemoCentryxCompletedHidradenitis Suppurativa | Acne InversaUnited States
-
ChemoCentryxCompletedImmunoglobulin A NephropathyUnited States, Sweden
-
Mario Negri Institute for Pharmacological ResearchChemoCentryxTerminated
-
ChemoCentryxMedpace, Inc.CompletedC3 Glomerulopathy (C3G)United States, Spain, France, Netherlands, Belgium, Canada, Denmark, Germany, Ireland, Italy, United Kingdom
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisJapan
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenRecruitingAntineutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
ChemoCentryxCompletedVasculitisFrance, United Kingdom, Germany, Belgium, Poland, Netherlands, Hungary, Austria, Sweden, Czechia
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.UnknownType 2 Diabetes Mellitus
-
ChemoCentryxMedpace, Inc.CompletedFocal Segmental Glomerulosclerosis | FSGS | GlomerulosclerosisUnited States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
-
ChemoCentryxCompletedType 2 Diabetes Mellitus | Diabetic NephropathyPoland, United Kingdom, Germany, Belgium, Hungary, Czechia
-
ChemoCentryxCompletedType 2 Diabetes Mellitus | Diabetic NephropathyNetherlands
-
ChemoCentryxTerminatedFocal Segmental GlomerulosclerosisUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.UnknownType 2 Diabetes MellitusChina
-
Jiangsu HengRui Medicine Co., Ltd.Beijing Tongren HospitalCompleted
-
Jiangsu HengRui Medicine Co., Ltd.People's Liberation Army General Hospital of Chengdu Military RegionCompletedType 2 DiabetesChina
-
RenJi HospitalAbelZeta Pharma Inc.RecruitingA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (CAR-AID)Systemic Lupus Erythematosus (SLE) | Neuromyelitis Optica Spectrum Disorders | Immune-Mediated Necrotizing Myopathy | Multiple Sclerosis-Relapsing-RemittingChina
-
AmgenCompletedHealthy VolunteersUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.UnknownType 2 Diabetes MellitusChina
-
University Hospital, Clermont-FerrandUnknownAcute BronchiolitisFrance
-
ChemoCentryxCompletedANCA-associated VasculitisUnited States, Canada
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
ChemoCentryxCompletedType 2 Diabetes MellitusGermany, New Zealand, Hungary, Czechia, Australia
-
Jiangsu HengRui Medicine Co., Ltd.China-Japan Friendship HospitalCompletedType 2 DiabetesChina
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompleted
-
Fudan UniversityRecruitingObesity | Atypical Endometrial Hyperplasia | Fertility IssuesChina
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States